BioVie Inc (BIVI)
0.46
-0.02
(-5.00%)
USD |
NASDAQ |
May 23, 16:00
0.46
0.00 (0.00%)
After-Hours: 20:00
BioVie Cash from Financing (Quarterly): 15.98M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.98M |
| December 31, 2023 | 4.922M |
| September 30, 2023 | -0.5942M |
| June 30, 2023 | 1.268M |
| March 31, 2023 | 9.768M |
| December 31, 2022 | 32.53M |
| September 30, 2022 | 11.81M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 14.61M |
| September 30, 2021 | 18.51M |
| June 30, 2021 | 0.1688M |
| March 31, 2021 | 0.5166M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 14.24M |
| June 30, 2020 | 0.3935M |
| March 31, 2020 | 0.402M |
| December 31, 2019 | 0.03M |
| September 30, 2019 | 0.50M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.264M |
| Date | Value |
|---|---|
| September 30, 2018 | 2.532M |
| June 30, 2018 | 0.227M |
| March 31, 2018 | 0.075M |
| December 31, 2017 | 0.14M |
| September 30, 2017 | 0.22M |
| June 30, 2017 | 0.095M |
| March 31, 2017 | 0.2995M |
| December 31, 2016 | 0.0975M |
| September 30, 2016 | 0.013M |
| June 30, 2016 | -0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.5942M
Minimum
Sep 2023
32.53M
Maximum
Dec 2022
6.252M
Average
0.5083M
Median
Cash from Financing (Quarterly) Benchmarks
| Adial Pharmaceuticals Inc | 3.824M |
| Precision BioSciences Inc | 40.10M |
| Cardiff Oncology Inc | 0.107M |
| Jaguar Health Inc | 12.27M |
| Entero Therapeutics Inc | 3.379M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.852M |
| Free Cash Flow | -35.23M |
| Free Cash Flow Per Share (Quarterly) | -0.1306 |
| Free Cash Flow Yield | -196.4% |